FY2017 EPS Estimates for DaVita HealthCare Partners Inc. Reduced by KeyCorp (DVA)

DaVita HealthCare Partners Inc. (NYSE:DVA) – Equities researchers at KeyCorp dropped their FY2017 earnings per share estimates for DaVita HealthCare Partners in a report released on Monday. KeyCorp analyst J. Gurda now forecasts that the firm will post earnings of $3.50 per share for the year, down from their previous estimate of $3.76. KeyCorp also issued estimates for DaVita HealthCare Partners’ FY2018 earnings at $3.96 EPS.

A number of other research analysts have also recently weighed in on DVA. Wells Fargo & Company reiterated an “outperform” rating on shares of DaVita HealthCare Partners in a report on Tuesday, November 1st. Jefferies Group reiterated a “buy” rating and issued a $70.00 target price (down previously from $86.00) on shares of DaVita HealthCare Partners in a report on Saturday, November 19th. Zacks Investment Research upgraded DaVita HealthCare Partners from a “strong sell” rating to a “hold” rating in a report on Friday, November 4th. Robert W. Baird cut DaVita HealthCare Partners from an “outperform” rating to a “neutral” rating and lifted their target price for the company from $68.00 to $69.00 in a report on Tuesday, December 13th. Finally, SunTrust Banks, Inc. set a $66.00 target price on DaVita HealthCare Partners and gave the company a “hold” rating in a report on Thursday, October 13th. Ten research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. DaVita HealthCare Partners has an average rating of “Hold” and a consensus price target of $74.00.

Earnings History and Estimates for DaVita HealthCare Partners (NYSE:DVA)

TRADEMARK VIOLATION WARNING: This piece was originally published by Community Financial News and is the propert of of Community Financial News. If you are viewing this piece on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The original version of this piece can be viewed at https://www.com-unik.info/2017/01/11/fy2017-eps-estimates-for-davita-healthcare-partners-inc-reduced-by-keycorp-dva.html.

DaVita HealthCare Partners (NYSE:DVA) traded down 0.709% on Wednesday, hitting $63.179. The stock had a trading volume of 1,452,775 shares. The stock has a market cap of $12.47 billion, a P/E ratio of 18.414 and a beta of 1.04. The company’s 50-day moving average is $64.58 and its 200-day moving average is $66.58. DaVita HealthCare Partners has a one year low of $54.50 and a one year high of $78.77.

DaVita HealthCare Partners (NYSE:DVA) last released its quarterly earnings data on Wednesday, November 2nd. The company reported $0.95 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.93 by $0.02. The business earned $3.73 billion during the quarter, compared to analysts’ expectations of $3.72 billion. DaVita HealthCare Partners had a return on equity of 16.16% and a net margin of 4.92%. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.12 EPS. TRADEMARK VIOLATION WARNING: This piece was originally published by Community Financial News and is the propert of of Community Financial News. If you are viewing this piece on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The original version of this piece can be viewed at https://www.com-unik.info/2017/01/11/fy2017-eps-estimates-for-davita-healthcare-partners-inc-reduced-by-keycorp-dva.html.

Hedge funds have recently made changes to their positions in the company. Checchi Capital Advisers LLC raised its stake in shares of DaVita HealthCare Partners by 2.4% in the second quarter. Checchi Capital Advisers LLC now owns 1,556 shares of the company’s stock valued at $120,000 after buying an additional 37 shares in the last quarter. Calvert Investment Management Inc. raised its stake in shares of DaVita HealthCare Partners by 0.6% in the second quarter. Calvert Investment Management Inc. now owns 10,300 shares of the company’s stock valued at $796,000 after buying an additional 57 shares in the last quarter. First Allied Advisory Services Inc. raised its stake in shares of DaVita HealthCare Partners by 1.2% in the second quarter. First Allied Advisory Services Inc. now owns 7,712 shares of the company’s stock valued at $592,000 after buying an additional 94 shares in the last quarter. Sii Investments Inc. WI raised its stake in shares of DaVita HealthCare Partners by 3.2% in the second quarter. Sii Investments Inc. WI now owns 3,984 shares of the company’s stock valued at $308,000 after buying an additional 124 shares in the last quarter. Finally, FDx Advisors Inc. raised its stake in shares of DaVita HealthCare Partners by 0.6% in the second quarter. FDx Advisors Inc. now owns 23,743 shares of the company’s stock valued at $1,836,000 after buying an additional 134 shares in the last quarter. 83.08% of the stock is currently owned by institutional investors and hedge funds.

DaVita HealthCare Partners Company Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. The Company’s segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives.

5 Day Chart for NYSE:DVA

What are top analysts saying about DaVita HealthCare Partners Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for DaVita HealthCare Partners Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit